weekly-digest Research (76)
76 papers in the weekly-digest topic, indexed by PF-Atlas from PubMed and global journals.
- TBDs: To test or not test. · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2026
- The emerging role of PDE4 inhibitors for the treatment of pulmonary fibrosis. · Expert review of clinical pharmacology · 2026
- Epidemiological and Clinical Characteristics of Interstitial Lung Diseases in Kuwait: A Nine-Year Single-Center Observational Prospective Study. · Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
- Review of the Impact of Weight Loss and Body Mass Index in Clinical Trials of Nintedanib in Interstitial Lung Disease. · Advances in therapy · 2026
- Characteristics, prognosis, and risk factors for relapse in patients with cryptogenic organizing pneumonia: A prospective cohort study in China. · Chinese medical journal · 2026
- Gastrointestinal and skin safety evaluation of pirfenidone versus nintedanib: an analysis of real-world pharmacovigilance and randomized controlled trials. · Naunyn-Schmiedeberg's archives of pharmacology · 2026
- Impact of time to diagnosis in patients with progressive fibrotic ILD: a systematic review. · BMJ open respiratory research · 2026
- Pirfenidone exerts anti-inflammatory effects by inhibiting CXCL6 to alleviate idiopathic pulmonary fibrosis. · International immunopharmacology · 2026
- Bronchoalveolar lavage fluid cytokine-based clustering identifies prognostically relevant cytokine phenotypes across interstitial lung diseases. · Respiratory investigation · 2026
- Prevalence and predictors of pulmonary hypertension in patients with progressive pulmonary fibrosis: A retrospective study. · Respiratory investigation · 2026
- Residential indoor air monitoring to assess long-term exposure to air pollution in susceptible populations for epidemiology: overview and early findings. · Environmental health : a global access science source · 2026
- Methodological Clarification is Needed Regarding Joinpoint Analyses and ICD-10 Coding of Idiopathic Pulmonary Fibrosis Mortality in Spain. · Archivos de bronconeumologia · 2026
- Cadherin-11 Regulation of Type II Alveolar Epithelial Cells During Pulmonary Fibrosis. · American journal of physiology. Cell physiology · 2026
- Pathological Th2 cell activation via STAT6 pathway for pulmonary fibrosis. · American journal of respiratory cell and molecular biology · 2026
- Dupilumab Alleviates Pulmonary Fibrosis by Interrupting Profibrotic Macrophage-Fibroblast Crosstalk and IL4R/JAK/STAT Signaling. · Lung · 2026
- Mannose-modified tobacco mosaic virus-mediated macrophage regulation inhibits pulmonary fibrosis progression. · Journal of materials chemistry. B · 2026
- Corrigendum to "Evaluation of radiological lung pattern and disease progression in patients with asbestosis compared to patients with idiopathic pulmonary fibrosis" [Respir. Med. 262, ]. · Respiratory medicine · 2026
- Randomised controlled trial of partitioned aerobic exercise training using one-leg cycling in patients with idiopathic pulmonary fibrosis. · Thorax · 2026
- Nintedanib for progressive pulmonary fibrosis associated with sarcoidosis: a retrospective preliminary observational report. · Respiratory investigation · 2026
- Type VI collagen is proportionally lower around airways and blood vessels in idiopathic pulmonary fibrosis. · American journal of physiology. Cell physiology · 2026
- Blood-based biomarkers associated with progressive pulmonary fibrosis in idiopathic inflammatory myositis-associated interstitial lung disease: A retrospective cohort study from a respiratory center. · Multidisciplinary respiratory medicine · 2026
- Development and validation of the Hypersensitivity Pneumonitis South Asian Questionnaire for Exposure : a novel, qualitative and quantitative tool. · Thorax · 2026
- Pirfenidone Lung Distribution Amplified in Idiopathic Pulmonary Fibrosis: Roles of tight junction disruption and drug transporter dysregulation. · European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2026
- Prevalence of distress and changes over time among patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. · Palliative & supportive care · 2026
- Connective Tissue Disease–Associated Interstitial Lung Disease. · 2026
- Short-term air pollution exposure and hospitalizations in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry. · Annals of the American Thoracic Society · 2026
- Mechanofusion-assisted magnesium stearate surface modification enhances dispersion and aerodynamic performance of carrier-based nintedanib inhalable dry powder formulations. · International journal of pharmaceutics · 2026
- Parameters predicting mortality in antifibrotic-treated IPF patients: mMRC, CPI, TLCO, FVC, GAP. · Biomarkers in medicine · 2026
- Circulating miRNA signature identifies stage-specific profiles in idiopathic pulmonary fibrosis. · American journal of respiratory cell and molecular biology · 2026
- Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis. · Animal models and experimental medicine · 2026
- Aberrant and ectopic cell populations in restrictive allograft syndrome after lung transplantation. · The European respiratory journal · 2026
- Progressive pulmonary fibrosis: a state-of-the-art review. · The European respiratory journal · 2026
- Targeting the Snail1-ATGL-ferroptosis-EMT axis via AKT-GSK3β signaling: Low-dose colchicine attenuates idiopathic pulmonary fibrosis. · European journal of pharmacology · 2026
- OSU-03012 mitigates pulmonary fibrosis by targeting ECM proteins via suppression of S6K-mediated translation and acceleration of MMP-driven clearance. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
- ROS/HIF-1 signalling in alveolar macrophages: implications for lung fibrosis. · American journal of physiology. Lung cellular and molecular physiology · 2026
- Inhibition of Extracellular Tissue Transglutaminase Activity Attenuates Development of Pulmonary Fibrosis in a Novel Rabbit Model. · American journal of physiology. Lung cellular and molecular physiology · 2026
- Iron and the lung: emerging roles of iron metabolism in pulmonary disease pathogenesis and therapy. · European respiratory review : an official journal of the European Respiratory Society · 2026
- Pulmonary arterial hypertension with signs of venous/capillary involvement in connective tissue diseases: paradigms and paradoxes. · European respiratory review : an official journal of the European Respiratory Society · 2026
- Circulating lipids, lipoproteins, and the risk of idiopathic pulmonary fibrosis: a cohort study and genetic analysis. · Journal of lipid research · 2026
- Type I interferon-activated myeloid states are associated with less fibrotic stages in idiopathic pulmonary fibrosis. · Cell reports · 2026
- Pleuroparenchymal fibroelastosis in a UK tertiary ILD centre: determinants of radiological progression and survival. · Respiratory medicine · 2026
- Management of Pulmonary Hypertension in Interstitial Lung Disease Without Access to Inhaled Treprostinil: A Case Series from a Resource-Limited Setting. · The American journal of the medical sciences · 2026
- Platelet GPVI drives fibrotic lung remodeling. · Blood advances · 2026
- The Ethics of Lung Cancer Education for Pulmonary Fibrosis Patients: Addressing Diagnostic Overshadowing and Cancer Risk. · Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
- End of rarity: the evolving burden of interstitial lung diseases in England - trends from a national population-based cohort study. · Thorax · 2026
- Evaluation of Pirfenidone as a Novel Radioprotectant for Radiation-induced Intestinal Injury. · Anticancer research · 2026
- Multi-omics integration reveals the CTSK-cholesterol metabolic axis and the cholesterol-RORA/LDLR paracrine axis in SPP1 macrophages as mediators of 6PPD-quinone-induced idiopathic pulmonary fibrosis. · Environmental pollution (Barking, Essex : 1987) · 2026
- Advances in Prognostic Assessment of Idiopathic Pulmonary Fibrosis: From Clinical-Physiological Parameters and Molecular Biomarkers to Multimodal Models. · Respiratory medicine · 2026
- Tarlatamab in Relapsed SCLC With Idiopathic Pulmonary Fibrosis: A Case With Comparative DLL3 Expression Analysis: Case Report. · JTO clinical and research reports · 2026
- Evaluation of radiological lung pattern and disease progression in patients with asbestosis compared to patients with idiopathic pulmonary fibrosis. · Respiratory medicine · 2026
- Deciphering the pulmonary fibrosis niche: A single-cell transcriptomic perspective on cellular crosstalk and microenvironment remodeling. · Cytokine & growth factor reviews · 2026
- Prognostic impact of autoimmune features in interstitial lung disease: a single-center retrospective real-world cohort study. · Clinical rheumatology · 2026
- Aberrant expression of the PREX2-MAGI2 axis modulates myofibroblast differentiation in pulmonary fibrosis. · American journal of physiology. Lung cellular and molecular physiology · 2026
- Occupational disease risks in natural resource-based industries among a large cohort of workers in Ontario, Canada. · Work (Reading, Mass.) · 2026
- MicroRNAs in IPF and lung cancer: convergent and divergent mechanisms: a systematic review. · American journal of physiology. Lung cellular and molecular physiology · 2026
- GSNOR reprograms nitrosylation to drive endothelial-to-mesenchymal transition and fibrotic vascular remodeling. · Redox biology · 2026
- Comparative study on mouse models of acute exacerbation of pulmonary fibrosis. · Experimental and therapeutic medicine · 2026
- Comprehensive assessment of complete blood count as a prognostic biomarker in interstitial lung diseases. · Respiratory medicine · 2026
- The gut speaks to the lung: Fecal microbiota and survival in idiopathic pulmonary fibrosis. · American journal of respiratory and critical care medicine · 2026
- Validation of claims-based algorithms for identifying selected interstitial lung disease . · Respiratory medicine · 2026
- A self-sustaining repair circuit drives the progression of pulmonary fibrosis. · Translational research : the journal of laboratory and clinical medicine · 2026
- ADAMTS14 is a novel modulator of fibroblast mechanoactivation in pulmonary fibrosis. · American journal of respiratory and critical care medicine · 2026
- Gradually, then suddenly: deconvoluting the natural history of idiopathic pulmonary fibrosis. · American journal of respiratory and critical care medicine · 2026
- Mycophenolate and azathioprine in fibrotic interstitial lung disease. · American journal of respiratory and critical care medicine · 2026
- Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: A Pulmonary Perspective on Recent Guidelines. · Advances in therapy · 2026
- Signal in the noise: polygenic scores and the problem of defining idiopathic pulmonary fibrosis. · American journal of respiratory and critical care medicine · 2026
- Short for their age: interpreting whole-genome telomere length in idiopathic pulmonary fibrosis. · American journal of respiratory and critical care medicine · 2026
- Association of a polygenic risk score with diagnosis and outcomes in idiopathic pulmonary fibrosis. · American journal of respiratory and critical care medicine · 2026
- A Phase I Study Assessing the Safety, Tolerability, and Pharmacokinetics of Yinfenidone: A Novel, Potent Drug for Idiopathic Pulmonary Fibrosis Treatment in Healthy Chinese Subjects. · Clinical therapeutics · 2026
- IL-11 neutralizing antibodies alleviate pulmonary fibrosis in aging mice by inhibiting TGF-β/NOX4/IL-11 signaling pathway. · Biochemical pharmacology · 2026
- Assessment of active fibrotic remodeling in patients with idiopathic pulmonary fibrosis /progressive pulmonary fibrosis using dual-time-point [ Ga]Ga-FAPI-46-PET/CT. · European journal of radiology · 2026
- Mitochondrial Dysfunction and Telomeric Shortening as Long-term Complications After COVID-19. · Archivos de bronconeumologia · 2026
- When does change become progression? Defining meaningful quantitative computed tomography thresholds in idiopathic pulmonary fibrosis. · American journal of respiratory and critical care medicine · 2026
- ac4C modification of PDK4 by NAT10 promotes pulmonary fibrosis by reprogramming mitochondrial dynamics in fibroblasts. · Free radical biology & medicine · 2026
- Performance of age-adjusted whole genome sequencing telomere length in idiopathic pulmonary fibrosis. · American journal of respiratory and critical care medicine · 2026
- Meaningful thresholds for change in quantitative computed tomography-derived fibrosis extent in idiopathic pulmonary fibrosis. · American journal of respiratory and critical care medicine · 2026
Medical disclaimer. Research listings are for information only and are not medical advice.